These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19369041)

  • 1. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo.
    Haas SE; Bettoni CC; de Oliveira LK; Guterres SS; Dalla Costa T
    Int J Antimicrob Agents; 2009 Aug; 34(2):156-61. PubMed ID: 19369041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Surface Characteristics of Polymeric Nanocapsules on the Pharmacokinetics and Efficacy of Antimalarial Quinine.
    Michels LR; Maciel TR; Nakama KA; Teixeira FEG; de Carvalho FB; Gundel A; de Araujo BV; Haas SE
    Int J Nanomedicine; 2019; 14():10165-10178. PubMed ID: 32021159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Curcuma Oil/Quinine-Loaded Nanocapsules for Malaria Treatment.
    Gomes GS; Maciel TR; Piegas EM; Michels LR; Colomé LM; Freddo RJ; Ávila DS; Gundel A; Haas SE
    AAPS PharmSciTech; 2018 Feb; 19(2):551-564. PubMed ID: 28875471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
    Leite EA; Grabe-Guimarães A; Guimarães HN; Machado-Coelho GL; Barratt G; Mosqueira VC
    Life Sci; 2007 Mar; 80(14):1327-34. PubMed ID: 17303179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain.
    Gupta Y; Jain A; Jain SK
    J Pharm Pharmacol; 2007 Jul; 59(7):935-40. PubMed ID: 17637187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-nanoencapsulation of antimalarial drugs increases their in vitro efficacy against Plasmodium falciparum and decreases their toxicity to Caenorhabditis elegans.
    Velasques K; Maciel TR; de Castro Dal Forno AH; Teixeira FEG; da Fonseca AL; Varotti FP; Fajardo AR; Ávila DS; Haas SE
    Eur J Pharm Sci; 2018 Jun; 118():1-12. PubMed ID: 29550283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium berghei: development of an irreversible experimental malaria model in Wistar rats.
    Pedroni HC; Bettoni CC; Spalding SM; Dalla Costa T
    Exp Parasitol; 2006 Jul; 113(3):193-6. PubMed ID: 16494867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial interaction of quinine and quinidine with clarithromycin.
    Pandey SK; Dwivedi H; Singh S; Siddiqui WA; Tripathi R
    Parasitology; 2013 Mar; 140(3):406-13. PubMed ID: 23137860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
    Joshi M; Pathak S; Sharma S; Patravale V
    Int J Pharm; 2008 Nov; 364(1):119-26. PubMed ID: 18765274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the visceral functions of Plasmodium berghei-infected and -uninfected rats following administration of artemether.
    Akomolafe RO; Adeoshun IO; Fakunle JB; Iwalewa EO; Ayoka AO; Akanji BO
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1180-3. PubMed ID: 17184498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.
    Isacchi B; Bergonzi MC; Grazioso M; Righeschi C; Pietretti A; Severini C; Bilia AR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):528-34. PubMed ID: 22142592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
    Mandawgade SD; Sharma S; Pathak S; Patravale VB
    Int J Pharm; 2008 Oct; 362(1-2):179-83. PubMed ID: 18652886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS; Crommelin DJ; Eling WM; Zuidema J
    J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biotransformation, in vivo efficacy and pharmacokinetics of antimalarial chalcones.
    Gutteridge CE; Thota DS; Curtis SM; Kozar MP; Li Q; Xie L; Zhang J; Melendez V; Asher CO; Luong TT; Gerena L; Nichols DA; Montip G
    Pharmacology; 2011; 87(1-2):96-104. PubMed ID: 21282967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment.
    Ishih A; Suzuki T; Muregi FW; Matsui K; Terada M
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinine distribution in pregnant mice with Plasmodium berghei malaria.
    Lirussi F; Pussard E
    Eur J Pharm Sci; 2006 Jul; 28(4):284-90. PubMed ID: 16716571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.
    Aditya NP; Patankar S; Madhusudhan B; Murthy RS; Souto EB
    Eur J Pharm Sci; 2010 Aug; 40(5):448-55. PubMed ID: 20493255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.
    Joshi M; Pathak S; Sharma S; Patravale V
    Int J Pharm; 2008 Oct; 362(1-2):172-8. PubMed ID: 18611435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy.
    Ibrahim N; Ibrahim H; Dormoi J; Briolant S; Pradines B; Moreno A; Mazier D; Legrand P; Nepveu F
    Int J Pharm; 2014 Apr; 464(1-2):214-24. PubMed ID: 24412521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial activity of 1-aryl-3,3-dialkyltriazenes.
    Nishiwaki K; Okamoto A; Matsuo K; Kawaguchi Y; Hayase Y; Ohba K
    Bioorg Med Chem; 2007 Apr; 15(8):2856-9. PubMed ID: 17329108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.